Kidswell Bio (TSE:4584) Payments of Debt: 円-1,413 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
44 GF Score
Price 円146.00
GF Value 円230.75
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Kidswell Bio Payments of Debt?

Kidswell Bio TSE:4584 -3.31% 44 Payments of Debt is 円-1,413 Mil as of Mar. 2026. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円230.75 (Possible Value Trap). The stock has 8 warning signs investors should review.

Kidswell Bio's Payments of Debt for the six months ended in Mar. 2026 was 円-1,084 Mil.

Kidswell Bio's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,413 Mil.


Kidswell Bio Payments of Debt Related Terms


Kidswell Bio Payments of Debt Historical Data

* Premium members only.

The historical data trend for Kidswell Bio's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio Payments of Debt Chart

Kidswell Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -150.00 -375.00 -737.04 -1,412.96

Kidswell Bio Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -200.00 -443.52 -293.52 -328.52 -1,084.44
TSE:4584
44GF Score
Kidswell Bio Corp TSE:4584
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kidswell Bio Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-1,413 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of 円-1,413 Mil mean?
Kidswell Bio (TSE:4584) has a Payments of Debt of 円-1,413 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Kidswell Bio and its competitors.
Is Kidswell Bio's Payments of Debt too high?
Kidswell Bio's current Payments of Debt is 円-1,413 Mil. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's Payments of Debt compare to VRTX and REGN?
Kidswell Bio's Payments of Debt of 円-1,413 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current Payments of Debt is 円-1,413 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円230.75, compared to a current price of 円146.00 — trading 36.7% below its estimated fair value. The current Payments of Debt is 円-1,413 Mil. Kidswell Bio's overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current Payments of Debt is 円-1,413 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円146.00 is trading 36.7% below its estimated GF Value™ of 円230.75. GuruFocus considers Kidswell Bio to be Possible Value Trap.

Key valuation signals for TSE:4584:

  • Payments of Debt: 円-1,413 Mil
  • GF Value™: 円230.75 vs. price of 円146.00 (36.7% below fair value)
  • GF Score™: 44/100 with 8 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
44GF Score

Get the complete analysis for TSE:4584

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円146.00
Price
円230.75
GF Value